Latest JOHNSON & JOHNSON Stock Portfolio

JOHNSON & JOHNSON Performance:

2025 Q4: 12.17%YTD: 49.8%2024: -16.62%

Performance for 2025 Q4 is 12.17%, and YTD is 49.8%, and 2024 is -16.62%.

About JOHNSON & JOHNSON and 13F Hedge Fund Stock Holdings

On 2026-02-13, the fund reported it's updated stock portfolio. In the 13F Holdings report, JOHNSON & JOHNSON reported an equity portfolio of $554.6 Millions as of 31 Dec, 2025.

The top stock holdings of JOHNSON & JOHNSON are PTGX, NBTX, . The fund has invested 38.6% of it's portfolio in PROTAGONIST THERAPEUTICS INC. and 23.4% of portfolio in NANOBIOTIX S.A.

The fund managers got completely rid off ARROWHEAD PHARMACEUTICALS, INC. (ARWR), ADICET BIO, INC. (ACET) and BIOMX INC. (PHGE) stocks. They significantly reduced their stock positions in CVRX, INC. (CVRX). JOHNSON & JOHNSON opened new stock positions in ADICET BIO, INC. (ACET).

JOHNSON & JOHNSON Annual Return Estimates Vs S&P 500

Our best estimate is that JOHNSON & JOHNSON made a return of 12.17% in the last quarter. In trailing 12 months, it's portfolio return was 49.8%.

Performance
S&P 500

New Buys

Ticker	$ Bought
adicet bio, inc.	191,803

New stocks bought by JOHNSON & JOHNSON

Additions

No additions were made to existing positions by JOHNSON & JOHNSON

Reductions

Ticker	% Reduced
cvrx, inc.	-1.91

JOHNSON & JOHNSON reduced stake in above stock

Sold off

Ticker	$ Sold
arrowhead pharmaceuticals, inc.	-8,539,660
adicet bio, inc.	-295,295
biomx inc.	-50,855
senseonics holdings, inc.	-23,804

JOHNSON & JOHNSON got rid off the above stocks

Sector Distribution

JOHNSON & JOHNSON has about 58.8% of it's holdings in Healthcare sector.

Sector	%
Healthcare	58.8
Others	41.2

Market Cap. Distribution

JOHNSON & JOHNSON has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.

Category	%
UNALLOCATED	41.2
MID-CAP	38.6
SMALL-CAP	13.9
MICRO-CAP	6.4

Stocks belong to which Index?

About 58.9% of the stocks held by JOHNSON & JOHNSON either belong to S&P 500 or RUSSELL 2000 index.

Index	%
RUSSELL 2000	58.9
Others	41.1

Top 5 Winners (%)		%
LYEL	lyell immunopharma, inc.	89.5 %
RLYB	rallybio corporation	37.5 %
PTGX	protagonist therapeutics inc.	31.5 %
XNCR	xencor, inc.	30.5 %
NBTX	nanobiotix s.a.	22.4 %

Top 5 Winners ($)		$
PTGX	protagonist therapeutics inc.	51.2 M
NBTX	nanobiotix s.a.	23.8 M
XNCR	xencor, inc.	2.7 M
	rapport therapeutics, inc.	1.1 M
RLYB	rallybio corporation	0.7 M

Top 5 Losers (%)		%
VOR	vor biopharma, inc.	-73.2 %
LEGN	legend biotech corporation	-33.3 %
NNOX	nano-x imaging ltd.	-24.3 %
FATE	fate therapeutics, inc.	-22.0 %
CVRX	cvrx, inc.	-11.9 %

Top 5 Losers ($)		$
LEGN	legend biotech corporation	-8.9 M
CVRX	cvrx, inc.	-3.9 M
VOR	vor biopharma, inc.	-1.9 M
MGTX	meiragtx holdings plc	-1.9 M
PRCT	procept biorobotics corporation	-1.5 M

JOHNSON & JOHNSON Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of JOHNSON & JOHNSON

JOHNSON & JOHNSON has 17 stocks in it's portfolio. About 98.4% of the portfolio is in top 10 stocks. LEGN proved to be the most loss making stock for the portfolio. PTGX was the most profitable stock for JOHNSON & JOHNSON last quarter.

Last Reported on: 13 Feb, 2026

Ticker	Namesorted ascending	% Portfolio	Shares Held	$ Value	Type	% Change
ACET	adicet bio, inc.	0.04	22,779	191,803	new

ACET	adicet bio, inc.	0.00	0.00	0.00	sold off	-100

ARWR	arrowhead pharmaceuticals, inc.	0.00	0.00	0.00	sold off	-100

CVRX	cvrx, inc.	5.15	4,024,860	28,576,500	reduced	-1.91

FATE	fate therapeutics, inc.	0.60	3,379,060	3,320,270	unchanged	0.00

LAB	standard biotools, inc.	0.07	311,967	399,318	unchanged	0.00

LEGN	legend biotech corporation	3.19	814,586	17,709,100	unchanged	0.00

LYEL	lyell immunopharma, inc.	0.23	41,165	1,267,060	unchanged	0.00

MGTX	meiragtx holdings plc	9.52	6,641,060	52,796,500	unchanged	0.00

NBTX	nanobiotix s.a.	23.44	5,623,820	130,023,000	unchanged	0.00

NNOX	nano-x imaging ltd.	0.08	158,852	444,786	unchanged	0.00

PHGE	biomx inc.	0.00	0.00	0.00	sold off	-100

PRCT	procept biorobotics corporation	2.03	357,939	11,260,800	unchanged	0.00

PTGX	protagonist therapeutics inc.	38.57	2,449,180	213,912,000	unchanged	0.00

RLYB	rallybio corporation	0.45	454,545	2,494,910	unchanged	0.00

SENS	senseonics holdings, inc.	0.00	0.00	0.00	sold off	-100

VOR	vor biopharma, inc.	0.13	53,732	702,815	unchanged	0.00

XNCR	xencor, inc.	2.06	748,062	11,452,800	unchanged	0.00

	rapport therapeutics, inc.	9.76	1,784,520	54,142,200	unchanged	0.00

	contineum therapeutics inc.	4.08	1,979,170	22,621,900	unchanged	0.00